Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

National Center for Research Resources (NCRR)

Status and phase: Completed; Phase 2

Conditions: Infant, Newborn, Diseases

Treatments: Drug: metoclopramide

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00008736

NCRR-M01RR00240-1724

Details and patient eligibility

About

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Sex: All

Ages: 1 minute to 1 month old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation